European Respiratory Society

The ERS Congress Bookshop is returning in 2022
Order now and collect in Barcelona: save money and guarantee your copy
Type 2 inflammation in asthma and other airway diseases
Asthma is a heterogenous disease. Targeted therapies have been developed based on the pathophysiology of type 2 inflammation. These therapies offer hope for improved management of type 2 inflammatory airway diseases.
Telemedicine and virtual respiratory care in the era of COVID-19
The COVID-19 pandemic has forced a dramatic shift to remote care and accelerated multiple telemedicine initiatives. As they evolve into the new norm, these initiatives must accommodate preferences and address the risk of increasing the digital divide.
Prevalence and burden of chronic cough in China: a national cross-sectional study
In the general adult population in China, chronic cough is prevalent and associated with poorer health status, especially in individuals aged ≥50 years and those with COPD or small airway dysfunction
Respiratory Failure and Mechanical Ventilation Conference 2022
Read the abstracts here

Latest Articles

BMI increase – A risk factor for FEV₁ decline for overweight and obese adults with asthma
Nicolás Bermúdez Barón, Hannu Kankaanranta, Linnea Hedman, Martin Andersson, Caroline Stridsman, Anne Lindberg, Eva Rönmark, Helena Backman

ERJ Open Research Jan 2022, 00110-2022; DOI: 10.1183/23120541.00110-2022
Vasoreactive phenotype in children with pulmonary arterial hypertension and syncope
Alexandra N. Linder, Jill Hsia, Sheila V. Krishnan, Erika B. Rosenzweig, Usha S. Krishnan

ERJ Open Research Jan 2022, 00223-2022; DOI: 10.1183/23120541.00223-2022
Two cases of nintedanib-induced diarrhoea treated using a 5-HT type 3 receptor antagonist
Toru Arai, Yoshikazu Inoue

ERJ Open Research Jan 2022, 00242-2022; DOI: 10.1183/23120541.00242-2022
Phase I studies of BI 1015550, a preferential PDE4B inhibitor, in healthy males and patients with idiopathic pulmonary fibrosis
Toby M. Maher, Christina Schlecker, Doreen Luedtke, Sebastian Bossert, Donald F. Zoz, Armin Schultz

ERJ Open Research Jan 2022, 00240-2022; DOI: 10.1183/23120541.00240-2022
All-cause admissions following a first-ever exacerbation-related hospitalization in COPD
Kiki Waeijen-Smit, Peter A. Jacobsen, Sarah Houben-Wilke, Sami O. Simons, Frits M. E. Franssen, Martijn A. Spruit, Christian T. Pedersen, Kristian H. Kragholm, Ulla M. Weinreich

ERJ Open Research Jan 2022, 00217-2022; DOI: 10.1183/23120541.00217-2022
Complete response to anti-IL5 biologics in a real-life setting
Marianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, Ole Hilberg, Sofie Lock-Johansson, Kjell Erik Julius Haakansson, Truls Sylvan Ingebrigtsen, Claus Rikard Johnsen, Linda Makowska Rasmussen, Anna von Bülow, Karin Dahl Assing, Johannes Martin Schmid, Charlotte Suppli Ulrik, Celeste Porsbjerg

ERJ Open Research Jan 2022, 00238-2022; DOI: 10.1183/23120541.00238-2022

About ERJ Open Research

ERJ Open Research is a fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine. It has a Journal Impact Factor of 4.2.

Tweets by @ERSpublications

Main menu

User menu

Search

Latest Articles

About ERJ Open Research

Contact us